Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2023-07-31 Regulatory Filings
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Board Meeting — HESTER BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company fo…
Regulatory Filings
2023-07-31 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled to consider the unaudited financial results for the quarter ended 30 June 2023. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which governs disclosures related to board meetings. The document does not contain any financial data or results itself, nor does it provide detailed financial analysis or report content. It is an announcement of a board meeting, not the financial report or results. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related disclosures.
2023-07-31 English
Updates
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate addressed to stock exchanges regarding securities dematerialised/rematerialised for the quarter ended 30 June 2023. It references compliance with SEBI regulations and includes a certificate from the Registrar and Share Transfer Agent. The document is short (1166 characters) and primarily serves as a regulatory compliance communication rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or detailed disclosures. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-07-08 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is an official communication from Hester Biosciences Limited to stock exchanges regarding the assignment and reaffirmation of credit ratings by CARE Ratings Limited. It includes detailed information about the credit facilities, rating actions, and terms of repayment. The document is a formal notification of credit rating updates pursuant to SEBI regulations. It does not contain financial statements, management discussion, or detailed financial performance analysis typical of annual or interim reports. It is not a call transcript, earnings release, or governance document. The content focuses on credit rating updates and related disclosures, which aligns with a Capital/Financing Update. The document length is over 12,000 characters, indicating it is a full update rather than a brief announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-07-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It informs the stock exchanges about the trading restrictions around the release of quarterly financial results. The document does not contain any financial data, results, or detailed report but is an announcement related to regulatory compliance and trading restrictions. It is short (1184 characters) and serves as a regulatory announcement rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2023-06-30 English
Press Release
Board/Management Information Classification · 95% confidence The document is a press release dated 27 June 2023 announcing the appointment of two non-executive and independent directors to the board of Hester Biosciences Limited. It includes detailed profiles of the new directors and information about the company. There is no financial data, no mention of financial results, no regulatory filings, no voting results, and no other report types. The content clearly relates to changes in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is about 5436 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is MANG with high confidence.
2023-06-27 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.